Schizophrenia with impulsive and aggressive behaviors

Area of Science:

• Psychiatry and Behavioral Sciences
• Neuroscience
• Pharmacology

Background:

• Impulsive and aggressive behaviors present significant clinical challenges in schizophrenia management.
• These behaviors manifest in both acute and chronic phases, necessitating diverse treatment approaches.

Purpose of the Study:

• To review and discuss effective interventions for managing impulsive and aggressive behaviors in schizophrenia.
• To highlight the importance of nonpharmacological strategies and available acute pharmacological options.
• To identify the need for improved long-term pharmacological treatments with better tolerability.

Main Methods:

• Review of current clinical practices and pharmacological options for schizophrenia-related behavioral disturbances.
• Emphasis on structured, organized, and nonconfrontational behavioral interventions.
• Discussion of available intramuscular antipsychotic formulations for acute symptom management.

Main Results:

• Behavioral and nonpharmacological interventions, including structure and a nonconfrontational approach, show success.
• A range of intramuscular antipsychotics provides rapid acute treatment with minimal sedation.
• Current long-term treatment options require further development for improved patient tolerability.

Conclusions:

• A combination of behavioral and pharmacological strategies is essential for managing aggression and impulsivity in schizophrenia.
• While acute management is supported by existing antipsychotics, there is a clear need for novel, well-tolerated long-term pharmacotherapies.
• Future research should focus on developing treatments that balance efficacy with an improved side-effect profile for chronic schizophrenia patients.